6[23]Dube M P, Johnson D L, Currier J S, et al. Protease inhibitor-associated hyperglycaemia[J]. Lancet, 1997, 350: 713-714.
7[24]Blanche s, Tardieu M, Rustin P, et al. Persistent mitochondrial dysfunction and perinatal exposure to antiretroviral nucleoside analogues[J]. Lancet, 1999, 354: 1084-1089.
8[25]Ciesielski C A, Metler R P, Msph R N. Duration of time betneen exposure and seroconversion in healthcare workers with occupationally acquired infection with human immunodeficiency virus[J]. Am J Med, 1997, 102(5B): 115-116.
9[26]Busch M P, Satten G A. Time course of viremia and antibody seroconversion following human immunodeficiency virus exposure[J]. Am J Med, 1997, 102(5B): 117-124.
10[27]Ridzon R, Gallagher K, Ciesielski C, et al. Simultaneous of human immunodeficiency virus and hepatitis C virus from a needle-stick injury[J]. N Engl J Med, 1997, 336(13): 919-922.
2Varghese GM,Abraham OC,Mathai D. Post-exposure proph- ylaxis for b|ood borne viral infections in healthcare workers [J]. Postgrad Med J,2003,79(932) :324-328.
3Brusaferro S,Calligaris L,Farneti F. Educational programmes and sharps injuries in health care workers [J]. Occup Med (Lond) ,2009,59(7) :512-514.
4Gershon RR,Pearson JM,Sherman MF,et al. The prevalence and risk factors for percutaneous injuries in registered nurses in tb.e home health care sector[J]. Am J Infect Control, 2009, 37(7) :5Z5-533.
5Bakaeen F, Awad S, Albo D,et al. Epidemiology of exposure to blood borne pathogens on a surgical service[J]. Am J Surg, 2006,192(5) :e18-21.
